These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6157513)

  • 21. [Studies of 57-co-bleomycin in patients with carcinoma colli uteri (author's transl)].
    Schober O; Mariss P; Pertynski T; Zimmermann P; Börner P
    Rofo; 1978 Jun; 128(6):754-7. PubMed ID: 79534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endobuccal verrucous epithelioma. Results of intra-arterial bleomycin].
    Greiner G; Walter P; Vu-Gi ; Boidevezi P; Waegele P
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1980 Nov; 29(9):603-5. PubMed ID: 6162909
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of chemotherapy on the distribution of 57Co-bleomycin in chemically induced squamous cell carcinoma of mouse skin.
    Pertynski T; Reznik G; Mariss P; Ketkar MB; Haindl H; Dieffenbach G
    Eur J Nucl Med; 1979 Feb; 4(1):55-9. PubMed ID: 91511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [57Co-bleomycetin pharmacokinetics in the body of mice with LIO-1 lymphosarcoma].
    Petriev VM; Vatin AE; Prusova RM; Filatov PP; Khachirov DG
    Antibiotiki; 1982 Aug; 27(8):623-6. PubMed ID: 6181732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of bleomycin after im administration in man.
    Oken MM; Crooke ST; Elson MK; Strong JE; Shafer RB
    Cancer Treat Rep; 1981; 65(5-6):485-9. PubMed ID: 6165473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Work in progress: the effect of heat on bleomycin cytotoxicity in vitro and on the accumulation of 57Co-bleomycin in heat-treated rat tumors.
    Lin PS; Cariani PA; Jones M; Kahn PC
    Radiology; 1983 Jan; 146(1):213-7. PubMed ID: 6184743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of bleomycin in cancer of the skin and visible mucosa].
    Khlebnov AV; Raben AS
    Klin Med (Mosk); 1973 Jul; 51(7):49-51. PubMed ID: 4132150
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of oral florid papillomatosis with bleomycin. Use of Holter catheter for intra-arterial administration.
    Hagedorn M; Weigel K; Petres J
    Arch Dermatol; 1978 Jul; 114(7):1083-4. PubMed ID: 80154
    [No Abstract]   [Full Text] [Related]  

  • 30. Intracellular distribution of 57Co-bleomycin.
    Konings AW; Rasker JJ; Posthuma GA
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):497-512. PubMed ID: 76527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new treatment of malignant brain tumor -1: local injection of bleomycin (author's transl)].
    Nakazawa S; Ohwaki K; Shimura T; Itoh Y; Yajima K
    No Shinkei Geka; 1981 Dec; 9(13):1487-93. PubMed ID: 6179006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptake of labelled tallysomycin by solid Ehrlich ascites tumors in mice.
    Liniecki J; Rembelska M; Koniarek B
    Nuklearmedizin; 1983 Jun; 22(3):159-61. PubMed ID: 6194513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental and clinical studies of local application of solid and oil bleomycins for the treatment of oral cancer.
    Sugimura M; Horibata K; Shiba R; Tanioka H; Takada K; Sakuda M
    J Maxillofac Surg; 1981 Feb; 9(1):26-34. PubMed ID: 6164741
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary fate of [3H]bleomycin A2 in mice.
    Lazo JS; Pham ET
    J Pharmacol Exp Ther; 1984 Jan; 228(1):13-8. PubMed ID: 6198509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tissue levels of bleomycin administered as suppository].
    Okado M; Matsumoto Y; Hamada Y; Yamamoto R; Hidaka R; Yamaoka K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1025-30. PubMed ID: 6191707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Distribution of various 57Co-labelled zhengguangmycin preparations in Ehrlich carcinoma bearing mice in relation with their antitumor activity and toxicity (author's transl)].
    Xue SB; Liu HT; Zhang HQ; Li DD; Lin HY
    Yao Xue Xue Bao; 1980 Jan; 15(1):1-6. PubMed ID: 6161520
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics of 57Co-bleomycetin accumulation in the primary tumor and in its metastases to the lungs in mice with Lewis carcinoma].
    Vatin OE; Petriev VM; Prusova RM
    Antibiotiki; 1983 Sep; 28(9):686-9. PubMed ID: 6195962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental and clinical studies on topical application of bleomycin in advanced esophageal cancer (author's transl)].
    Okudaira Y
    Fukuoka Igaku Zasshi; 1978 Apr; 69(4):127-45. PubMed ID: 78880
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with intratumor application of bleomycin-oil suspension (BOS) in cancers of the mouth, oropharynx and maxillary sinus].
    Mika H
    HNO; 1982 Dec; 30(12):457-61. PubMed ID: 6186651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.